Literature DB >> 21135844

Building bone from blood vessels.

Edwin M Horwitz.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 21135844     DOI： 10.1038/nm1210-1373

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  13 in total

1.  Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

Authors:  E M Horwitz; K Le Blanc; M Dominici; I Mueller; I Slaper-Cortenbach; F C Marini; R J Deans; D S Krause; A Keating
Journal:  Cytotherapy       Date:  2005       Impact factor: 5.414

2.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

Review 3.  How do mesenchymal stromal cells exert their therapeutic benefit?

Authors:  E M Horwitz; M Dominici
Journal:  Cytotherapy       Date:  2008       Impact factor: 5.414

4.  A perivascular origin for mesenchymal stem cells in multiple human organs.

Authors:  Mihaela Crisan; Solomon Yap; Louis Casteilla; Chien-Wen Chen; Mirko Corselli; Tea Soon Park; Gabriella Andriolo; Bin Sun; Bo Zheng; Li Zhang; Cyrille Norotte; Pang-Ning Teng; Jeremy Traas; Rebecca Schugar; Bridget M Deasy; Stephen Badylak; Hans-Jörg Buhring; Jean-Paul Giacobino; Lorenza Lazzari; Johnny Huard; Bruno Péault
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

5.  The heterogeneity of human mesenchymal stem cell preparations--evidence from simultaneous analysis of proteomes and transcriptomes.

Authors:  Wolfgang Wagner; Robert E Feldmann; Anja Seckinger; Martin H Maurer; Frederik Wein; Jonathon Blake; Ulf Krause; Armin Kalenka; Heinrich F Bürgers; Rainer Saffrich; Patrick Wuchter; Wolfgang Kuschinsky; Anthony D Ho
Journal:  Exp Hematol       Date:  2006-04       Impact factor: 3.084

6.  Mesenchymal and haematopoietic stem cells form a unique bone marrow niche.

Authors:  Simón Méndez-Ferrer; Tatyana V Michurina; Francesca Ferraro; Amin R Mazloom; Ben D Macarthur; Sergio A Lira; David T Scadden; Avi Ma'ayan; Grigori N Enikolopov; Paul S Frenette
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

7.  Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood.

Authors:  Wolfgang Wagner; Frederik Wein; Anja Seckinger; Maria Frankhauser; Ute Wirkner; Ulf Krause; Jonathon Blake; Christian Schwager; Volker Eckstein; Wilhelm Ansorge; Anthony D Ho
Journal:  Exp Hematol       Date:  2005-11       Impact factor: 3.084

8.  Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6.

Authors:  Ryang Hwa Lee; Andrey A Pulin; Min Jeong Seo; Daniel J Kota; Joni Ylostalo; Benjamin L Larson; Laura Semprun-Prieto; Patrice Delafontaine; Darwin J Prockop
Journal:  Cell Stem Cell       Date:  2009-07-02       Impact factor: 24.633

9.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide.

Authors:  Guangwen Ren; Liying Zhang; Xin Zhao; Guangwu Xu; Yingyu Zhang; Arthur I Roberts; Robert Chunhua Zhao; Yufang Shi
Journal:  Cell Stem Cell       Date:  2008-02-07       Impact factor: 24.633

10.  Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone.

Authors:  Edwin M Horwitz; Patricia L Gordon; Winston K K Koo; Jeffrey C Marx; Michael D Neel; Rene Y McNall; Linda Muul; Ted Hofmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205
View more
  5 in total

Review 1.  Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons.

Authors:  Robert J Pignolo; Eileen M Shore; Frederick S Kaplan
Journal:  Pediatr Endocrinol Rev       Date:  2013-06

2.  Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition.

Authors:  Guoyu Yu; Paul G Corn; Pengfei Shen; Jian H Song; Yu-Chen Lee; Song-Chang Lin; Jing Pan; Sandeep K Agarwal; Theocharis Panaretakis; Maurizio Pacifici; Christopher J Logothetis; Li-Yuan Yu-Lee; Sue-Hwa Lin
Journal:  Cancer Res       Date:  2022-09-02       Impact factor: 13.312

Review 3.  EndMT-derived mesenchymal stem cells: a new therapeutic target to atherosclerosis treatment.

Authors:  Xiaofan Zhang; Zhong Ren; Zhisheng Jiang
Journal:  Mol Cell Biochem       Date:  2022-09-09       Impact factor: 3.842

4.  High glucose mediates endothelial-to-chondrocyte transition in human aortic endothelial cells.

Authors:  Rining Tang; Min Gao; Min Wu; Hong Liu; Xiaoliang Zhang; Bicheng Liu
Journal:  Cardiovasc Diabetol       Date:  2012-09-22       Impact factor: 9.951

Review 5.  Regulation of endothelial cell plasticity by TGF-β.

Authors:  Laurens A van Meeteren; Peter ten Dijke
Journal:  Cell Tissue Res       Date:  2011-08-25       Impact factor: 5.249
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.